RT Journal Article SR Electronic T1 Treatment of acute myeloid leukaemia JF Clinical Medicine JO Clin Med FD Royal College of Physicians SP s58 OP s61 DO 10.7861/clinmedicine.13-6-s58 VO 13 IS Suppl 6 A1 Alan K Burnett YR 2013 UL http://www.rcpjournals.org/content/13/Suppl_6/s58.abstract AB Acute myeloid leukaemia is a heterogeneous disease that occurs in all age groups but peaks in older age at around a median of 69–70 years where it has a frequency of 13–15/100,00/annum. With the changing demographics, the number of cases will increase in line with the older population. As the only treatment with curative intent is intensive chemotherapy, this presents an immediate therapeutic challenge for the majority of the disease.